SCHEMBL3175833

SCHEMBL3175833

COc1ccccc1N1CCN(CC(=O)Nc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD4 P21917 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ ALDH1A1 P00352 6/20 0.51
▸ TSHR P16473 4/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ KDM4E B2RXH2 3/20 0.50
▸ GAA P10253 1/20 0.50
▸ USP2 O75604 1/20 0.50
▸ HTT P42858 2/20 0.49
▸ SLC6A2 P23975 1/20 0.48
▸ SLC6A4 P31645 1/20 0.48
▸ DRD2 P14416 3/20 0.47
▸ DRD3 P35462 3/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169692 0.92 ADORA3 (0.47) DRD4MAPTALDH1A1TSHRKMT2A
SCHEMBL3175773 0.89 GAA (0.55) MAPTALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL3163835 0.88 MEN1 (0.46) DRD4ALDH1A1MEN1KMT2AKDM4E
SCHEMBL3172699 0.88 ALDH1A1 (0.51) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL3162425 0.87 EGFR (0.53) MAPTALDH1A1TSHRMEN1KMT2A
SCHEMBL3175718 0.87 DRD4 (0.51) DRD4MAPTALDH1A1KDM4EGAA
SCHEMBL3175820 0.87 MEN1 (0.46) DRD4MAPTALDH1A1MEN1KMT2A
SCHEMBL3165286 0.87 USP2 (0.57) DRD4MAPTALDH1A1TSHRMEN1
SCHEMBL3156668 0.86 MAPT (0.59) DRD4MAPTALDH1A1TSHRMEN1
SCHEMBL3160939 0.85 ALDH1A1 (0.52) DRD4ALDH1A1TSHRSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback